| Abstrakt: |
Keywords: Seoul; South Korea; Asia; Antibodies; Blood Proteins; Cancer; Cancer Therapy; Drugs and Therapies; Emerging Technologies; Gold Nanoparticles; Health and Medicine; Immunoglobulins; Immunology; Nanoparticles; Nanotechnology; Oncology; Proteins EN Seoul South Korea Asia Antibodies Blood Proteins Cancer Cancer Therapy Drugs and Therapies Emerging Technologies Gold Nanoparticles Health and Medicine Immunoglobulins Immunology Nanoparticles Nanotechnology Oncology Proteins 1083 1083 1 10/30/23 20231103 NES 231103 2023 OCT 31 (NewsRx) -- By a News Reporter-Staff News Editor at Drug Week -- Current study results on Cancer have been published. However, currently available antibody therapies are restricted to target proteins in the outer cell membrane or in the extracellular fluids because of the lack of technologies for effective intracellular delivery of antibodies." Seoul, South Korea, Asia, Antibodies, Blood Proteins, Cancer, Cancer Therapy, Drugs and Therapies, Emerging Technologies, Gold Nanoparticles, Health and Medicine, Immunoglobulins, Immunology, Nanoparticles, Nanotechnology, Oncology, Proteins. [Extracted from the article] |
